NOS1 and pulmonary fibrosis: NOS activity is altered in DM and decreased NO bioavailability resulting from increased iNOS activity in an oxidative environment has been implicated in the development of renal and pulmonary fibrosis and could contribute to lung fibrosis (Figure 3).